Journal of the National Cancer Institute

Journal of the National Cancer Institute  
Abbreviated title (ISO 4)
 J. Natl. Cancer Inst.
Discipline Oncology
Language English
Edited by Dr. Patricia Ganz
Publication details
Publisher
Publication history
 1940–present
Frequency Monthly
12.589
Indexing
ISSN 0027-8874 (print)
1460-2105 (web)
CODEN JNCIEQ
OCLC no. 01064763
Links
Journal of the National Cancer Institute Monographs  
Abbreviated title (ISO 4)
 J. Natl. Cancer Inst. Monogr.
Discipline Oncology
Language English
Edited by Dr. Patricia Ganz
Publication details
Publisher
Publication history
 1959–present
12.589
Indexing
ISSN 1052-6773 (print)
1745-6614 (web)
LCCN 94660018
OCLC no. 21986096
Links

The Journal of the National Cancer Institute (JNCI) is a peer-reviewed medical journal covering research in oncology that was established in August 1940. It is published twice per month by Oxford University Press and is edited by Carmen J. Allegra. It was merged with Cancer Treatment Reports in January 1988. JNCI used to be the official journal of the National Cancer Institute (NCI), however in 1996 the NCI and JNCI agreed to grow apart. Over the next five years, JNCI became independent of the NCI.

A related publication is Journal of the National Cancer Institute Monographs (JNCI Monographs), established in 1959, which publishes manuscripts from cancer and cancer-related conferences, as well as groups of papers on specific subjects related to cancer. In January 1986, Cancer Treatment Symposia was merged with JNCI Monographs.

History

The history of JNCI is linked to that several other journals. A full history of JNCI and JNCI Monographs is presented below.

About the Journal[11]

The Journal celebrated its 75th anniversary in 2015, with a special collection of landmark papers, along with contemporary editorials reflecting on the impact of the publications. The 75th anniversary virtual collection and editorials can be found at https://academic.oup.com/jnci/pages/75th_Anniversary. The Journal began continuous digital publishing in 2014, allowing rapid continuous publication of manuscripts with their final digital identifier, and subsequent placement in a published volume (published monthly), with editorials, articles, reviews, and commentaries being organized together at that time. With this change, publication delays were reduced, and a single citation simplified publication date reporting. Further, the Journal transitioned to a newer editorial management system and was rebranded with an updated cover design that is graphically linked to other JNCI-related publications.

During the past two years, the Journal has developed a series of virtual collections curated from prior publications. These thematically organized collections focus on timely selected topics and are featured online with free access for several months. You can be notified of their release by signing up for new issues and advance article alerts on the JNCI website at https://academic.oup.com/jnci. Past collections include breast cancer, cancer policy, cervical cancer, colorectal cancer, and global cancer prevention and control, with one on melanoma that is available now. Finally, we have streamlined a number of our editorial processes to shorten the time to first decision, and ultimately hasten the rapid communication of new scientific findings. Improving upon our current time to first decision will be one of my highest priorities.

Some new things are in the works. JNCI has just launched JNCI Cancer Spectrum (JNCI CS) as an international, peer-reviewed, open access journal, publishing across the spectrum of oncology research. JNCI CS is ably led by Dr. Pamela Goodwin as its inaugural Editor-in-Chief. JNCI CS welcomes articles in basic, translational, and clinical research, prevention, screening, treatment, epidemiology, public health, and policy. In addition to novel results, the JNCI CS will also consider studies with meaningful confirmatory or negative findings, and it will encourage systematic reviews, meta-analyses, and expert reviews of important topics. It will also consider scholarly manuscripts discussing emerging hypotheses and research priorities. Dr. Goodwin and I have been professional colleagues for many years, and we both have extensive editorial management experience at the Journal of Clinical Oncology. We hope to capitalize on this relationship as the two journals collaborate, but with each maintaining a distinctive focus and scope.

Editorial Board

Dr. Patricia Ganz serves as the editor-in-chief with Drs. Carmen Allegra and Frederic Kaye as deputy editors. A full list of associate editors can be found on the journal's website. [12]

Submissions information[13]

Submission Procedures

Authors must submit manuscripts electronically via the Journal's Web-based submission system and use the Journal's Web site; submissions will not be accepted by e-mail or in hard copy.

Electronic Submission

Manuscripts may be submitted at the Journal’s online submission Web site, www.editorialmanager.com/jnci. The submitter will indicate the files to be uploaded, and then identify these files. 

Editorial Policies[14]

The Journal of the National Cancer Institute publishes manuscripts that describe new findings of particular significance in any area relating to cancer, as well as associated news items, reviews, and commentaries. The Journal employs a process of rigorous yet rapid review of submitted manuscripts so that findings of high scientific and medical interest can be published with minimum delay.

The Journal encourages submission of reports of randomized controlled clinical trials and will provide expedited review of such manuscripts.

Review of manuscripts is conducted by the editorial board, with the assistance of external reviewers. The editorial board initially reviews all submitted manuscripts and, whenever possible, responds to authors within 2 weeks regarding any paper that is judged to be of insufficient priority for further consideration. Scientific papers of high interest will be sent out for external review.

Authors will be notified of acceptance, rejection, or need for revision as soon as the external reviews are available. All revised manuscripts are edited to ensure conformity with Journal style and editorial standards. Authors are strongly encouraged to adhere to the revised manuscript guidelines provided in the provisional acceptance letter when revising their manuscripts. Acceptance is contingent on author submission of complete and consistent data, accurate reference list, and conclusions consistent with results demonstrated in the study. Inconsistencies and inaccuracies found after acceptance may warrant return of the manuscript for resubmission. The decision to publish a manuscript is solely the responsibility of the editorial board. Opinions expressed by the authors are not necessarily those of the publisher or the editors.

The Journal is a member of the Committee on Publication Ethics (COPE) and follows COPE guidelines with respect to handing ethical issues, including misconduct and retractions.

Abstracting and indexing

JNCI is indexed and abstracted in:

According to the Journal Citation Reports, the journal has a 2014 impact factor of 12.583, ranking it 8th out of 211 journals in the category "Oncology".[17]

JNCI Monographs is indexed and abstracted in

  • Abstracts in Anthropology
  • Abstracts on Hygiene and Communicable Diseases
  • BIOSIS Previews[15]
  • CAB Abstracts
  • CINAHL
  • Excerpta Medica
  • Nutrition Abstracts and Reviews
  • Oncology information service
  • Pharmacoeconomics and Outcome News
  • Reactions Weekly
  • The Standard Periodical Directory

References

  1. ↑ "Journal of the National Cancer Institute". National Library of Australia. Retrieved 2010-08-09.
  2. ↑ "National Cancer Institute Monograph". National Library of Australia. Retrieved 2010-08-09.
  3. 1 2 "Cancer Chemotherapy Reports". National Library of Australia. Retrieved 2010-08-09.
  4. 1 2 "Cancer Chemotherapy Reports. Part 1". National Library of Australia. Retrieved 2010-08-09.
  5. 1 2 "Cancer Chemotherapy Reports. Part 2". National Library of Australia. Retrieved 2010-08-09.
  6. 1 2 "Cancer Chemotherapy Reports. Part 3". National Library of Australia. Retrieved 2010-08-09.
  7. 1 2 "Cancer Treatment Symposia". National Library of Australia. Retrieved 2010-08-09.
  8. ↑ "Cancer Treatment Reports". National Library of Australia. Retrieved 2010-08-09.
  9. ↑ "NCI Monographs". National Library of Australia. Retrieved 2010-08-09.
  10. ↑ "The Journal of the National Cancer Institute and Its Relation to NCI: Fact Sheet". National Cancer Institute. Archived from the original on 22 July 2010. Retrieved 2010-08-09.
  11. ↑ Ganz, Patricia A. (2017-07-01). "Editorial: Changing of the Guard at the Journal of the National Cancer Institute". JNCI: Journal of the National Cancer Institute. 109 (7). ISSN 0027-8874. doi:10.1093/jnci/djx120.
  12. ↑ "Editorial Board | JNCI: Journal of the National Cancer Institute | Oxford Academic". academic.oup.com. Retrieved 2017-08-11.
  13. ↑ "Submission | JNCI: Journal of the National Cancer Institute | Oxford Academic". academic.oup.com. Retrieved 2017-08-11.
  14. ↑ "Policies | JNCI: Journal of the National Cancer Institute | Oxford Academic". academic.oup.com. Retrieved 2017-08-11.
  15. 1 2 3 4 5 "Master Journal List". Intellectual Property & Science. Thomson Reuters. Retrieved 2014-12-20.
  16. ↑ "Journal of the National Cancer Institute". NLM Catalog. National Center for Biotechnology Information. Retrieved 2014-12-20.
  17. ↑ "Journals Ranked by Impact: Oncology". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.